
Genetic Technologies for Hemophilia
This information sheet is designed to help understand the similarities, differences, and current state of knowledge for the existing genetic
Year: 2011
Language: English
This resource is also available in: Spanish
Author(s): Albert Farrugia, Alok Srivastava, Mark Brooker, Jeffrey S. Stonebraker, Paula H.B. Bolton-Maggs
Presents data on the reported use of factor IX (FIX) per country. FIX use varies considerably, even among the wealthiest countries, and increases with economic capacity. Trends also suggest that consumption of FIX has been increasing at a greater rate in high-income countries.

This information sheet is designed to help understand the similarities, differences, and current state of knowledge for the existing genetic

The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained”

The World Federation of Hemophilia invited representatives from its national member organizations, national governments, healthcare providers, industry partners, and other

A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy. Learn more about different treatment options